Sales revenues for December 2023

Sofia, Bulgaria, January 22, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for December 2023 the Company recorded a decrease in sales of 57% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 68% decrease in export sales.

For 2023 the revenues from sales of products increase by 7%, incl. 1% increase of sales for the domestic market and 11% increase in export sales.